The takeaway
Imax Corp shows a pronounced seasonal pattern over 10 years of data — strongest in February (+6.4%) and softest in June (−4.3%).
Right now
In July, the stock has risen 70% of years, averaging +1.5%, roughly 0.6 pts behind the S&P 500.
The full picture
Imax Corp's most dependable month has been February, higher in 8 of 10 years; June has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in February (+6.6 pts); it has trailed the market most in March (−5.6 pts).
“vs S&P” is Imax Corp’s average for a month minus the S&P 500’s average for that same month — isolating Imax Corp’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, February has closed higher 100% of the time versus 80% across the last 10 years — the pattern is strengthening.
Figures are the typical (median) February return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
Strip the year back and a single month does the heavy lifting: February, up in 8 of 10 Februaries while the other eleven tend to blur together.
Its average (+6.4%) and median (+5.5%) land within a hair of each other — the tell of steady, year-after-year gains rather than one outlier doing the work. It is among its calmest months, too, its returns swinging least from year to year (a 8.3% spread), and even its worst February in 10 years lost only 7.4% — the gentlest downside anywhere on its calendar. Crucially, the gain is the stock's own rather than a rising tide's: February has cleared the S&P 500 by +6.6 points above the index. It bucks the broad tape, besides: February lifts just 49% of stocks across the market.
A few other months pull their weight: April, May, and July have also closed higher more often than not. At the other end of the calendar, June has been the soft spot — the weakest of 5 months that average a loss (−4.3%), and the edge isn't year-round — the stock has trailed the S&P 500 in March, June, and January. Its roughest month on record was a −41.6% March in 2020 — a reminder of how hard even a seasonal name can fall.
February has now closed higher 5 years running. If anything it has sharpened recently — the last five Februaries run ahead of the earlier years.
The takeaway is less about when to buy than what to expect: February aside, the stock's months offer little reliable tilt.
Short answers on the stock's best month (February), its worst (June), and whether it really trades seasonally.
Yes, to a pronounced degree. Since 2016 its best month (February, +6.4%) has run well ahead of its worst (June, −4.3%) — the heatmap above shows how steady that gap has been year to year.
February has been the strongest, averaging +6.4% and closing higher in 8 of 10 years since 2016.
It's the weakest, averaging −4.3% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade